Peter Stathis

Peter Stathis has a diverse work experience in the pharmaceutical and biotechnology industry. Peter is currently the Head of Technical Operations at Surrozen, a position they have held since April 2020. Prior to that, they worked as the Senior Director of Technical Operations at Amphivena Therapeutics Inc. from January 2019 to June 2019. Before that, they held the role of Senior Director of Drug Substance Manufacturing at ARMO BioSciences from May 2018 to July 2018. From April 2017 to April 2018, Peter worked as a Bioprocess and CMC Expert and Consultant, being self-employed. Peter spent a significant part of their career at OncoMed Pharmaceuticals, where they held the position of Senior Director of Process Development and Manufacturing from January 2008 to April 2017, leading a team of 18 individuals and overseeing various aspects of process development, tech transfer, and GMP manufacturing. Prior to that, they worked at Johnson & Johnson as an Associate Director of Purification Process Development from March 2003 to April 2007, and at Scios as the Department Head of Purification Process Development from January 1997 to February 2003.

Peter Stathis has a Bachelor of Arts - BA degree in Biology/Biological Sciences, General from the College of the Holy Cross. Information regarding the start and end year of this education is not provided.